Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: GB Group CFO ups stake

(Sharecast News) - GB Group revealed on Monday that chief financial officer David Ward had acquired 10,000 ordinary shares in the AIM-listed identity verification and fraud prevention company. Ward, who took over as CFO in July 2021, purchased the shares on Friday at an average price of 230.70p each, for a total value of £23,070.

Following the purchase, Ward has a beneficial holding of 97,000 ordinary GB shares, representing 0.04% of the company's issued share capital.

As of 1635 GMT, GB shares were up 0.60% at 233.60p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Big Technologies (BIG) Director name: Morris,Daren John Amount purchased: 32,500 @ 191.00p Value: �62,075.00

Gb Group (GBG) Director name: ward,David Amount purchased: 10,000 @ 230.70p Value: �23,070.00

Bbgi Global Infrastructure S.a. Npv (di) (BBGI) Director name: Rosenborg,Jutta af Amount purchased: 8,000 @ 133.60p Value: �10,688.00

Mila Resources (MILA) Director name: Daniels,Lee Amount purchased: 1,212,121 @ 0.83p Value: �10,000.00

Mpac Group (MPAC) Director name: Wilkins,Will Amount purchased: 4,813 @ 207.50p Value: �9,986.98

Jpmorgan Uk Smaller Companies Investment Trust (JMI) Director name: Hart,Katrina Amount purchased: 3,755 @ 264.67p Value: �9,938.17

Keystone Positive Change Investment Trust (KPC) Director name: Hart,Katrina Amount purchased: 4,690 @ 211.87p Value: �9,936.65

Redcentric (RCN) Director name: Brotherton,Peter Amount purchased: 7,020 @ 128.20p Value: �8,999.64

Fusion Antibodies (FAB) Director name: Kinkaid,Adrian Amount purchased: 101,847 @ 4.90p Value: �4,990.50

Fusion Antibodies (FAB) Director name: Douglas,Simon Gordon Amount purchased: 100,565 @ 4.96p Value: �4,988.02

Heiq (HEIQ) Director name: Brade ,Karen Amount purchased: 32,287 @ 15.37p Value: �4,963.16

Staffline Group (STAF) Director name: Spain,Thomas Amount purchased: 13,580 @ 23.65p Value: �3,211.67

Top Director Sells

London Stock Exchange Group (LSEG) Director name: Brand,Martin Amount sold: 37,329 @ $101.23 Value: $3,116,034.30

London Stock Exchange Group (LSEG) Director name: Brand,Martin Amount sold: 27,945 @ $101.23 Value: $2,332,705.90

Taseko Mines Limited Npv (di) (TKO) Director name: McDonald,Stuart Amount sold: 100,000 @ $1.67 Value: $137,709.24

Maxcyte (di) (MXCT) Director name: Doerfler ,Doug Amount sold: 5,350 @ $5.00 Value: $22,069.25

(ITH) Director name: Myerson,Gilad Amount sold: 1,822,286 @ 1.00p Value: �18,222.86

Share this article

Related Sharecast Articles

Director dealings: Roadside Real Estate CEO makes share purchase
(Sharecast News) - Roadside Real Estate revealed on Friday that Tarncourt Capital, an entity controlled by chief executive Charles Disckson, had acquired 19.76m ordinary shares in the AIM-listed energy forecourt real estate business.
Director dealings: Sthree CEO raises stake
(Sharecast News) - Sthree revealed on Thursday that chief executive Timo Lehne had acquired 20,427 shares in the London-listed staffing specialist.
Director dealings: Next director makes share purchase
(Sharecast News) - Next revealed on Wednesday that independent non-executive director Jeni Mundy had acquired 160 ordinary shares in the FTSE 100-listed retailer.
Director dealings: IG Group chairman snaps up shares
(Sharecast News) - IG Group revealed on Tuesday that chairman Andrew Barron had acquired 36,416 ordinary shares in the FTSE 100-listed fintech firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.